| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |